C A S E S T U D Y Pediatric Asthma Toll- Free (USA): 888-987-2691 mcsmo@makrocare.com www.makrocare.com/MCSMO USA I UK I EUROPE I ASIA Study Design: Phase III, Randomized, Double blind, Placebo controlled study to evaluate the Safety and tolerability of study drug in Pediatric Asthma patients. Challenges: • Stringent eligibility criteria • High screen failure rate • Parents/patients unwillingness to

Join for free to read